| Literature DB >> 33922153 |
Pariya Zare1, Mina Aleemardani2, Amelia Seifalian3,4, Zohreh Bagher5, Alexander M Seifalian6.
Abstract
Desirable carbon allotropes such as graphene oxide (GO) have entered the field with several biomedical applications, owing to their exceptional physicochemical and biological features, including extreme strength, found to be 200 times stronger than steel; remarkable light weight; large surface-to-volume ratio; chemical stability; unparalleled thermal and electrical conductivity; and enhanced cell adhesion, proliferation, and differentiation properties. The presence of functional groups on graphene oxide (GO) enhances further interactions with other molecules. Therefore, recent studies have focused on GO-based materials (GOBMs) rather than graphene. The aim of this research was to highlight the physicochemical and biological properties of GOBMs, especially their significance to biomedical applications. The latest studies of GOBMs in biomedical applications are critically reviewed, and in vitro and preclinical studies are assessed. Furthermore, the challenges likely to be faced and prospective future potential are addressed. GOBMs, a high potential emerging material, will dominate the materials of choice in the repair and development of human organs and medical devices. There is already great interest among academics as well as in pharmaceutical and biomedical industries.Entities:
Keywords: 3D scaffold; carbon; cell adhesion; functionalization; graphene; graphene oxide; human organs; interface; stem cells
Year: 2021 PMID: 33922153 PMCID: PMC8143506 DOI: 10.3390/nano11051083
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Schematic of graphene oxide nanomaterials and their application in tissue engineering, particularly in nerve, muscle, heart, skin, cartilage, dental, and other tissues.
Figure 2Graphene, graphene oxide, and reduced graphene oxide synthesis methods [9].
Summary of preclinical studies of graphene-oxide-based materials in tissue engineering from 2017.
| Organs | Materials | Animal | Cells/Stem Cells | Experiment | Outcome | Year [Ref] |
|---|---|---|---|---|---|---|
| Cartilage | Gelatin (G) and GO | Rats | Human chondrosarcoma cell, rat BMSCs, and | Preparing nano-GO (NGO) solution => hydrogel crosslinking => three groups: non-crosslinked hydrogel (NGO (U)), crosslinked hydrogel (NGO(T)), control group (G) | NGO(T) vs. NGO(U): ↑ mechanical properties. No significant cytotoxicity | 2020 [ |
| Nervous system | GO, antheraea pernyi silk fibroin (ApF) and PLCL | Rats | Schwann and PC12 cells | Coating GO on ApF/PLCL nanofibers => GO reduction => applying ES => preparing the AP/RGO nerve guidance conduit | ↑ CPAM and ↑ MPs. GO: ↑ focal adhesion kinase expression of PC12 cells. ↑ Repair in animal model’s sciatic nerve | 2019 [ |
| Muscle | GO, rGO, polyacry- lamide (PAAm) | Mice | C2C12 myoblasts | Incorporating GO into PAAm (GO-PAAm) => micropatterning of GO-PAAm with femtosecond laser ablation (FLA) => production of micropatterned conductive r(GO/PAAm) | Micropatterned: | 2019 [ |
| Heart | GO, rGO and alginate | Rats with MI | Human mesenchymal stem cells | GO/Ag blend => hMSCs encapsulation => electrospraying and then crosslinking => GO/Ag microgels => reductive treatment => r(GO/Ag) | rGO vs. GO: ↑ CPAM, | 2019 [ |
| Bone | GO and poly(ɛ-caprolactone) | Rat | MC3T3 preosteoblastic cells | Synthesizing GO => PCL/GO pellets => melt blending => 3D printing | ↑ Protein absorbent and ↑ CPAM | 2019 [ |
| Skin | Polydopamine (P), rGO (pGO), chitosan (CS), and silk fibroin (SF) (pGO-CS/SF) | Rats with a full-thickness skin defect | RAW 2467 cells and | Dispersing pGO into CS/SF mixture=> dual-crosslinking by poly(ethylene glycol) diglycidyl ether (PEGDE) and glutaraldehyde (GA) => freeze-drying => pGO-CS/SF scaffold | ↑ CPAM and ↑ mechanical properties | 2019 [ |
| Nervous system | Single (SG) and multilayered (GM) graphene PCL, RGD, polydopamine | Rats | Schwann cells | Fabricating nanoscaffolds => seeding Schwann cells => implanting the 3D scaffold in sciatic nerve defect models. | ↑ CPAM and ↑ neural cell expressionPDA/RGD-SG/PCL and PDA/RGD-MG/PCL nerve conduits: ↑ neural regeneration | 2018 [ |
| Heart | GO, gold nanoparticles (AuNPs) (GO-AuNPs), chitosan (CS) | Rats with MI | Rat smooth muscle cells, mouse fibroblasts, and human iPSC-CMs | GO => embedding with AuNPs by thermal-reduction => GO-AuNPs => CS solution addition and freeze-drying => CS-GO-Au scaffolds | ↑ Electrical conductivity (at 0.5% w/v GO- AuNPs). | 2018 [ |
| Dental | GO, chitosan (CS), hydroxyapatite (HA) and Titanium (Ti) | Rats | Bone marrow stromal cells (BMSCs) | Coating GO/CS/HA on Ti substrates by electrophoretic deposition (EPD) | ↑ CPAM and ↑ osseointegration in vivo | 2018 [ |
| Dental | GO and Collagen | Dog | Mouse osteoblastic MC3T3-E1 cells | Coating Ti on the 3D collagen scaffold => evaluation of bone augmentation on the rat cranial bone => assessing the periodontal healing of class II furcation defects | ↓ Cytotoxicity. | 2018 [ |
| Nervous system | GO, rGO, and Gelatin | Rats | Embryonic neural progenitor cells | Synthesizing rGO microfibers from GO => assembling rGO microfibers into the 3D gelatin hydrogel for stable implantation | Microfiber coated with adhesive molecules => interconnected culture | 2017 [ |
| Bone | GO and chitosan (CHT) | Mice | Murine preosteoblasts belonging to the 3T3-E1 cell line | CHT/GO blend => freeze-drying | ↑ Alkaline phosphatase activity (ALP), ↑ osteogenesis, and ↑ bone morphogenetic protein expression | 2017 [ |
| Bone | rGO and nanohydroxyapatite (nHA) | Rabbits | Bone mesenchymal stem cells | Self-assembling of GO and nHA => nHA@RGO | ↑ CPAM, ↑ ALP, and ↑ osteogenic gene expression | 2017 [ |
Keys: ↑, increased or improved; ↓, decreased; =>, followed by; CPAM, cellular proliferation, adhesion, and migration; SD, Sprague–Dawley; MPs, mechanical properties; HM, Hummer’s method; ES, electrical stimulation.
The most common stem cells utilized in each tissue [24,26,32,90].
| Tissue | Stem cells |
|---|---|
| Bone | hMSCs, hADMSCs, MC3T3-E1, DPSCs, PDLSCs |
| Nerve | NSCs, hMSCs, hADMSCs, ESCs, iPSCs, SCAP |
| Muscle and cardiac | C2C12, MSCs, hMSCs, cardiomyocytes, and EC |
| Cartilage | Human mesenchymal stem cell |
| Skin | MSCs, human dermal fibroblasts (HDFs) |
| Dental | DPSCs, PDLSCs, hMSCs, BMSCs |
Keys: hADMSCs, human adipose-derived mesenchymal stem cells; DPSCs, dental pulp stem cells; PDLSCs, periodontal ligament stem cells; NSCs, neural stem cells; ESCs, embryonic stem cells; iPSCs, induced pluripotent stem cells; SCAP, stem cell from apical papilla; BMSCs, bone-marrow-derived stem cells; C2C12, mouse myoblasts; EC, endothelial cells.
Figure 3Schematic illustration of (A) the LBLC graphene nerve conduit. (a) The green layers are PDA/RGD adhesive macromolecules. The purple layer is single or multilayered graphene and the PCL-blended layer. The blue layer is the graphene and PCL-blended layer once more. (b) The GO/PCL nerve conduit in a sciatic nerve defect model in SD rats. Reused with permission from [30]. Copyright © 2021, Springer Nature. (B) rGO/alginate microgel embedding MSCs for cardiac tissue repair post-MI. Due to the loaded rGO, it was expected that encapsulated MSCs were protected from the severe oxidative stress in the infarcted tissue and facilitated cardiac regeneration. Reused with permission from [27]. Copyright © 2021, Elsevier Ltd. (C) CS-DA-GO composite hydrogel fabrication in three steps, which causes the enhanced properties of the hydrogel. (A) Self-healing mechanism of the hydrogel. (B) Self-adhesiveness of the hydrogel. (C) Enhanced conductivity. Reused with permission from [29]. Copyright © 2021, Elsevier Ltd.
Figure 4(A) Pseudocolored SEM images of human osteoblasts that successfully adhered to the surface of scaffolds at an upward trend (Days 1, 3, and 7). Reused with permission from [58]. Copyright © 2021, Elsevier Ltd. (B) Surgical procedure of the preparation of the surgical size defect (5 mm) critical in the rat calvarium (a–c), placement of the chitosan–graphene oxide scaffold (d), and closure of the periosteum and skin (e,f). Reused with permission from [64]. Copyright © 2021, Springer Nature.
Figure 5(A) Wound healing of the skin through the treatment of various scaffolds. (a) Model of wound regeneration. Digital images (b) and closure rate (c) of the wound defects; multiple treatments at Days 0, 7, 14, and 21. (d) Depictive images of H&E-stained histological sections after 21 days (arrows indicate the granulation tissue). Reused with permission from [68]. Copyright © 2021 American Chemical Society. (B) (a) A normal rat knee joint; (b) knee joint restoration in different experimental groups (M: without implant; GO-NGO (U): non-crosslinked hydrogel; GO-NGO (T): microplasma crosslinked hydrogel) i 4 and 8 weeks. Reused with permission from [24]. Copyright © 2021 American Chemical Society.
Figure 6The prohibition effect of GO on biofilm formation. Reused with permission from [90]. Copyright © 2021 WILEY-VCH Verlag GmbH and Co. KGaA, Weinheim.
Figure 7Graphical conclusion.
Figure 8Schematic illustration of the cellular toxicity of GOBMs when exposed to the cell. GOBMs enter the cell through various pathways, which affects their shape, size, and surface chemistry and eventually results in ROS production. An increased ROS level may cause mitochondrial membrane depolarization and Ca2+ release; lipid, protein, and DNA damage; and inflammation response by releasing cytokines and chemokines.